DK0499541T3 - Fremgangsmåde til oprensning af et kraftigt glycosylerert protein - Google Patents

Fremgangsmåde til oprensning af et kraftigt glycosylerert protein

Info

Publication number
DK0499541T3
DK0499541T3 DK92400381.7T DK92400381T DK0499541T3 DK 0499541 T3 DK0499541 T3 DK 0499541T3 DK 92400381 T DK92400381 T DK 92400381T DK 0499541 T3 DK0499541 T3 DK 0499541T3
Authority
DK
Denmark
Prior art keywords
purification
strong
glycosylated protein
protein
mixture
Prior art date
Application number
DK92400381.7T
Other languages
English (en)
Inventor
Hanno Kolbe
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of DK0499541T3 publication Critical patent/DK0499541T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/816—Enzyme separation or purification by solubility

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK92400381.7T 1991-02-15 1992-02-13 Fremgangsmåde til oprensning af et kraftigt glycosylerert protein DK0499541T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9101830A FR2672895B1 (fr) 1991-02-15 1991-02-15 Procede de purification d'une proteine fortement glycosylee.

Publications (1)

Publication Number Publication Date
DK0499541T3 true DK0499541T3 (da) 1996-12-02

Family

ID=9409766

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92400381.7T DK0499541T3 (da) 1991-02-15 1992-02-13 Fremgangsmåde til oprensning af et kraftigt glycosylerert protein

Country Status (9)

Country Link
US (1) US5276141A (da)
EP (1) EP0499541B1 (da)
JP (1) JP3376430B2 (da)
AT (1) ATE141283T1 (da)
CA (1) CA2061167C (da)
DE (1) DE69212660T2 (da)
DK (1) DK0499541T3 (da)
ES (1) ES2092067T3 (da)
FR (1) FR2672895B1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
US5760189A (en) * 1995-06-02 1998-06-02 Genetics Institute, Inc. Protein recovery & purification methods
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
MXPA01013264A (es) * 1999-06-25 2002-06-04 American Cyanamid Co Extracion de proteinas de membrana integral.
WO2001027275A1 (en) * 1999-10-13 2001-04-19 Lexicon Genetics Incorporated Novel human membrane proteins
US7777006B2 (en) * 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
AU2004309177A1 (en) * 2003-12-30 2005-07-14 Bharat Biotech International Limited A process for the preparation and purification of recombinant proteins
WO2008145021A1 (en) * 2007-05-29 2008-12-04 Xiamen University A truncated l1 protein of human papillomavirus 6
US20160130324A1 (en) 2014-10-31 2016-05-12 Shire Human Genetic Therapies, Inc. C1 Inhibitor Fusion Proteins and Uses Thereof
US20180334493A1 (en) 2015-11-19 2018-11-22 Shire Human Genetic Therapies, Inc. Recombinant human c1 esterase inhibitor and uses thereof
CN113453712A (zh) * 2018-12-28 2021-09-28 特兰斯吉恩股份有限公司 M2缺陷型痘病毒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947324A (en) * 1975-04-21 1976-03-30 G. D. Searle And Co. Method for isolating high purity peroxidase
JPS6098988A (ja) * 1983-11-01 1985-06-01 Chemo Sero Therapeut Res Inst Ｌｐｆ−ｈａの精製法
EP0213099A3 (de) * 1985-08-23 1989-07-19 Cederroth Nordic Aktiebolag Mittel mit antiphlogistischer, immunstimulierender und zytoprotektiver Wirkung, ihre Herstellung und pharmazeutische Verwendungen
US4798886A (en) * 1986-03-24 1989-01-17 Takeda Chemical Industries, Ltd. Mutual separation of proteins
FR2597344B1 (fr) * 1986-04-16 1989-06-23 Merieux Inst Perfectionnement au procede de purification d'antigenes proteiques de bacteries appartenant au genre bordetella, en vue de l'obtention d'un vaccin acellulaire.
JPS63216898A (ja) * 1987-01-30 1988-09-09 インターナシヨナル・ミネラルズ・アンド・ケミカル・コーポレイシヨン 希薄水溶液からソマトトロビンを回収する方法
ES2059355T3 (es) * 1987-12-23 1994-11-16 Immuno Ag Proteinas anfipaticas celulares en forma de agregados y procedimiento para la produccion y la purificacion de estas proteinas.
US4992372A (en) * 1989-02-02 1991-02-12 Pokora Alexander R Method for removing impurities from peroxidase solutions
US5101014A (en) * 1989-02-10 1992-03-31 United States Of America Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis

Also Published As

Publication number Publication date
DE69212660D1 (de) 1996-09-19
EP0499541B1 (fr) 1996-08-14
CA2061167C (fr) 2002-06-11
US5276141A (en) 1994-01-04
CA2061167A1 (fr) 1992-08-16
FR2672895A1 (fr) 1992-08-21
DE69212660T2 (de) 1997-03-13
ATE141283T1 (de) 1996-08-15
JP3376430B2 (ja) 2003-02-10
ES2092067T3 (es) 1996-11-16
JPH04312600A (ja) 1992-11-04
FR2672895B1 (fr) 1995-05-12
EP0499541A1 (fr) 1992-08-19

Similar Documents

Publication Publication Date Title
DK0839196T3 (da) Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner
ZA963593B (en) IL-6 activity inhibitor
DK0499541T3 (da) Fremgangsmåde til oprensning af et kraftigt glycosylerert protein
DK332684D0 (da) Modificerede protease-inhibitorer samt deres fremstilling og anvendelse
MX9304638A (es) Composicion para tratar e inhibir las ulceras gastricas y duodenales.
DK496489D0 (da) Fremgangsmaade til stabilisering af proteiner ved tilrettelaeggelse af indbyrdes elektrostatiske paavirkninger ved metalionbindingssteder
FI960073A0 (fi) Proteiinien erottaminen
WO2003035679A3 (en) Molecules
EP0385118A3 (en) Use of compounds containing or binding sialic acid to neutralize bacterial toxins
DK1908772T3 (da) Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
DK0672192T3 (da) Fremgangsmåde til inhibering af virusmorfogenese
DK0546087T3 (da) Proteinstruktur af plantetoksinet gelonin
DK0504307T3 (da) Fremgangsmåde til behandling af septisk shock
DE69133172D1 (de) Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum
DE69526087D1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
DE3762409D1 (de) Verfahren zur aufarbeitung von abwaessern aus rauchgasreinigungsanlagen.
DK0668877T3 (da) Fortrængningschromatografisk fremgangsmåde og oprenset hæmoglobinprodukt
SE9604532D0 (sv) Transgenic plants having increased freezing tolerance
ATE477267T1 (de) Methode zur reinigung von proteinen
ATE81496T1 (de) Verfahren zur reinigung von dihydroxybiphenylen.
ATE95062T1 (de) Zusammensetzung zur behandlung von krebs, gekennzeichnet durch ueberexpression des c-fmsproto-onkogens.
IT8746819A0 (it) Barra a doppia funzione per il trattamento di colture al coperto, come le coltivazioni in serra
ATE62146T1 (de) Verfahren zur entschwefelung von rauchgasen aus kraftwerkskesselfeuerungen.
TH33439A (th) ส่วนประกอบที่เกี่ยวกับยาสำหรับโรคถ่ายปัสสาวะมาก